Chenodeoxycholic Acid

Chenodeoxycholic acid (CDCA) is a primary bile acid synthesized in the liver from cholesterol. It is the most abundant bile acid in human bile and plays a critical role in lipid digestion and absorption. This product is supplied as a white to off-white crystalline powder with ≥98% purity (HPLC), specifically graded for pharmaceutical and research applications.

CDCA is used as an active pharmaceutical ingredient (API) in the treatment of gallstones (cholelithiasis) and is also a key intermediate in the synthesis of other bile acids like ursodeoxycholic acid (UDCA). Its amphipathic nature makes it valuable in formulation science, particularly for enhancing drug solubility and bioavailability.

동의어: Chenodeoxycholic acid, CDCA, 3α,7α-Dihydroxy-5β-cholanic acid, 5β-Cholanic acid-3α,7α-diol, Chenodiol, Chenix, 474-25-9

응용 분야

• API for gallstone dissolution therapy (pharmaceutical formulations)
• Starting material for semi-synthetic bile acid derivatives (e.g., UDCA)
• Research reagent in lipid metabolism and bile acid signaling studies
• Excipient or solubilizer in drug delivery systems

품질 및 문서화

Every batch is tested for assay (HPLC ≥98%), loss on drying (≤1.0%), heavy metals (≤10 ppm), and residual solvents. Full COA, MSDS, and TDS are available on request. Stability data can be provided for qualification purposes.

포장 및 공급

표준 포장: 1kg, 5kg, 25kg. 맞춤형 포장 및 대량 공급도 가능합니다. 재고가 있는 상품은 3~5일 이내에 발송됩니다. 최소 주문 수량(MOQ)은 1kg부터입니다. 가격, 샘플 또는 대량 주문에 대해서는 영업팀에 문의해 주십시오.

견적 요청

• 주소: 중국 산시성 시안시 메인 스트리트 280번지
• LyvBio 주식회사. — 이메일: info@lyvbio.com